文献速递神经头颈MR

垂体大腺瘤侵袭性行为的生物标志物:一项3T常规MRI与DWI研究

Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study.
PubMed 文献 · Br J Radiol · 2020-07-06

研究纳入17例经手术切除的垂体大腺瘤患者,在3T扫描仪上评估常规MRI特征、T1W/T2W信号强度定量、对比增强率(ER)及ADC值,并与Ki67标记指数对照。Ki-67 LI与ADCm(ρ=-0.67,P=0.005)及ER值(ρ=-0.62,P=0.008)呈负相关,增殖组ER值显著更低(P=0.028;P=0.017);作者认为在常规MRI中加入ADC定量测量可作为垂体大腺瘤增殖活性的一种无创预测生物标志物。

要点

  • ADCm与Ki-67 LI呈负相关(ρ=-0.67,P=0.005),ADCm越低提示增殖活性越高。
  • ER值与Ki-67 LI呈负相关(ρ=-0.62,P=0.008),增殖组ER值显著低于非增殖组(P=0.028;P=0.017)。

关键影像表现/征象

  • Ki-67 LI与ADCm呈负相关(ρ=-0.67,P=0.005),与ER值呈负相关(ρ=-0.62,P=0.008)。
  • 增殖性垂体大腺瘤组的ER值显著低于非增殖组(P=0.028;P=0.017)。

诊断标准与关键数值

  • ADCm预测Ki67-LI值的敏感度为90%、特异度为85%。

临床应用与阅片要点

  • 作者认为在垂体腺瘤诊断流程中常规使用DWI可能有助于判断病变可能的生物学侵袭性。
  • 作者认为可将ADC值定量测量加入常规MRI,作为垂体大腺瘤增殖活性的无创预测生物标志物常规使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Pituitary macroadenomas (PAs) are usually defined as benign intracranial tumors. However, they may present local aggressive course. High Ki67 labelling index (LI) values have been related to an aggressive tumor behavior. A recent clinicopathological classification of PA based on local invasiveness and proliferation indexes, divided them in groups with different prognosis. We evaluated the utility of conventional MRI (cMRI) and diffusion-weighted imaging (DWI), in predicting the Ki67- LI according the clinicopathological classification.

METHODS: 17 patients (12 M and 5 F) who underwent surgical removal of a PA were studied. cMRI features, quantification of T1W and T2W signal intensity, degree of contrast uptake (enhancement ratio, ER) and apparent diffusion coefficient (ADC) values were evaluated by using a 3 T scan. Statistics included Mann-Whitney test, Spearman's test, and receiver operating characteristic analysis. A value of p ≤ 0.05 was considered significant for all the tests.

RESULTS: Negative correlations were observed between Ki-67 LI, ADCm (ρ = - 0.67, p value = 0.005) and ER values (ρ = -0.62; p = 0.008). ER values were significantly lower in the proliferative PA group (p = 0.028; p = 0.017). ADCm showed sensitivity and specificity of 90 and 85% respectively into predict Ki67-LI value. A value of ADCm ≤0, 711 x 10-6 mm2 emerged as a cut-off of a value of Ki67-LI ≥ 3%.

CONCLUSION: Adding quantitative measures of ADC values to cMRI could be used routinely as a non-invasive marker of specific predictive biomarker of the proliferative activity of PA.

ADVANCES IN KNOWLEDGE: Routinely use of DWI on diagnostic work-up of pituitary adenomas may help in establish the likely biological aggressive lesions.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Conficoni A, Feraco P, Mazzatenta D, et al. Biomarkers of pituitary macroadenomas aggressive behaviour: a conventional MRI and DWI 3T study. Br J Radiol. 2020. PMID: 32628097. doi:10.1259/bjr.20200321

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。